177 related articles for article (PubMed ID: 12019130)
1. Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.
Kiri N; Archer G; Climo MW
Antimicrob Agents Chemother; 2002 Jun; 46(6):2017-20. PubMed ID: 12019130
[TBL] [Abstract][Full Text] [Related]
2. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
Climo MW; Ehlert K; Archer GL
Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
[TBL] [Abstract][Full Text] [Related]
3. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
Climo MW; Patron RL; Archer GL
Antimicrob Agents Chemother; 1999 Jul; 43(7):1747-53. PubMed ID: 10390234
[TBL] [Abstract][Full Text] [Related]
4. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
[TBL] [Abstract][Full Text] [Related]
5. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
[TBL] [Abstract][Full Text] [Related]
6. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
Climo MW; Patron RL; Goldstein BP; Archer GL
Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
Polak J; Della Latta P; Blackburn P
Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040
[TBL] [Abstract][Full Text] [Related]
8. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
Hirano L; Bayer AS
Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374
[TBL] [Abstract][Full Text] [Related]
9. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Rand KH; Houck HJ
Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
[TBL] [Abstract][Full Text] [Related]
10. Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication.
Walencka E; Sadowska B; Rozalska S; Hryniewicz W; Rózalska B
Pol J Microbiol; 2005; 54(3):191-200. PubMed ID: 16450834
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic expression of oxacillin resistance in Staphylococcus epidermidis: roles of mecA transcriptional regulation and resistant-subpopulation selection.
Dickinson TM; Archer GL
Antimicrob Agents Chemother; 2000 Jun; 44(6):1616-23. PubMed ID: 10817718
[TBL] [Abstract][Full Text] [Related]
12. The utility of non-beta-lactam antimicrobial MICs as markers to distinguish oxacillin-resistant from oxacillin-susceptible strains of Staphylococcus epidermidis.
Fass RJ; Barnishan J; Ayers LW
Diagn Microbiol Infect Dis; 1996 Sep; 26(1):43-5. PubMed ID: 8950529
[TBL] [Abstract][Full Text] [Related]
13. Comparative activities of telavancin combined with nafcillin, imipenem, and gentamicin against Staphylococcus aureus.
Leonard SN; Supple ME; Gandhi RG; Patel MD
Antimicrob Agents Chemother; 2013 Jun; 57(6):2678-83. PubMed ID: 23545527
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin.
Watanakunakorn C; Glotzbecker C
Antimicrob Agents Chemother; 1977 Sep; 12(3):346-8. PubMed ID: 907328
[TBL] [Abstract][Full Text] [Related]
15. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
[TBL] [Abstract][Full Text] [Related]
16. Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models.
Hertlein T; Sturm V; Lorenz U; Sumathy K; Jakob P; Ohlsen K
Antimicrob Agents Chemother; 2014; 58(3):1630-8. PubMed ID: 24366730
[TBL] [Abstract][Full Text] [Related]
17. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
Sande MA; Courtney KB
J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
Walencka E; Sadowska B; Rózalska S; Hryniewicz W; Rózalska B
Folia Microbiol (Praha); 2006; 51(5):381-6. PubMed ID: 17176756
[TBL] [Abstract][Full Text] [Related]
19. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of cefotiam against oxacillin-resistant Staphylococcus epidermidis strains--reevaluation of beta-lactam antibiotics efficiency on MRSE.
Nakamura A; Oguri T; Misawa S; Tabe Y; Kondo S; Miyake K; Miyake N; Igari J; Ohsaka A
Jpn J Antibiot; 2007 Jun; 60(3):153-60. PubMed ID: 17867489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
